Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Alternative EBNA1 express… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Alternative EBNA1 expression in organ transplant patients.

Artikel i vetenskaplig tidskrift
Författare Malin Berggren
Åsa Isaksson
Ulrica Larsson
Folke Nilsson
Ulla Nyström
Tor Ekman
Jane Löfvenmark
Anne Ricksten
Publicerad i Journal of medical virology
Volym 76
Nummer/häfte 3
Sidor 378-85
ISSN 0146-6615
Publiceringsår 2005
Publicerad vid Hjärt-kärlinstitutionen
Institutionen för särskilda specialiteter, Avdelningen för onkologi
Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi/transfusionsmedicin
Sidor 378-85
Språk en
Länkar dx.doi.org/10.1002/jmv.20369
Ämnesord 5' Untranslated Regions, Adolescent, Adult, Alternative Splicing, Blotting, Western, Cell Line, Child, Child, Preschool, Epstein-Barr Virus Nuclear Antigens, biosynthesis, genetics, Exons, Female, Herpesvirus 4, Human, genetics, Humans, Infant, Leukocytes, virology, Male, Middle Aged, Organ Transplantation, RNA, Messenger, analysis, genetics, RNA, Viral, analysis, Reverse Transcriptase Polymerase Chain Reaction, Sweden, Transfection
Ämneskategorier Cancer och onkologi, Transplantationskirurgi

Sammanfattning

In order to identify patients at risk for developing post-transplant lymphoproliferative disease (PTLD), a sensitive nested RT-PCR method for detection of EBNA1 gene expression in peripheral blood cells was used. EBNA1 expression in peripheral blood samples from 60 organ recipients was analyzed and compared with 24 healthy controls in a retrospective study. Overall, EBNA1-positive samples were detected at least once in 43% of the transplant patients with post-transplant lymphoproliferative disease, in 18% of the other transplant patients and in none of the healthy controls. The odds ratio for EBNA1 expression in patients with post-transplant lymphoproliferative disease was 3.42 (95% CI=1.02-11.54) compared to other transplant recipients. Together with normal EBV Q promoter initiated EBNA1 transcripts, an alternatively spliced form was expressed in peripheral blood cells in the above-mentioned transplant patients. This transcript lacks the U leader exon in the 5'-untranslated region (UTR). We have previously identified and characterized a functional internal ribosome entry site, the EBNA IRES, in the untranslated U leader exon of EBNA1. Transfection experiments with EBNA1 coding plasmids followed by Western blot showed that the EBNA IRES promotes cap-independent translation and increases the EBNA1 protein level. The alternative EBNA1 transcript lacking this function is expressed in the majority of the investigated EBNA1-positive patient samples as well as in some EBV-positive B-cell lines. Alternative splicing in this form gives EBV potential to regulate the translation of EBNA1 by modifying the 5' UTR. These findings indicate a new mechanism for EBNA1 expression in vivo.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?